Mineralys Therapeutics Inc (MLYS)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-04-15 | 2025-04-14 | PS Planned sale |
Chief Medical Officer Officer |
1,000
-7.0%
14.83USD 124,572 |
1,000 -7.0% | 14.83 | USD 100,000 | |
| 2025-04-15 | 2025-04-14 | PS Planned sale |
Chief Medical Officer Officer |
1,000
-2.4%
13.69USD 40,613 |
1,000 -2.4% | 13.69 | USD 100,000 | |
| 2025-04-15 | 2025-04-11 | PS Planned sale |
Chief Executive Officer Executive Director |
1,000
-1.7%
12.19USD 186,803 |
1,000 -1.7% | 12.19 | USD 100,000 | |
| 2025-04-15 | 2025-04-11 | PS Planned sale |
CFO and Secretary Officer |
1,000
-4.8%
12.06USD 129,684 |
1,000 -4.8% | 12.06 | USD 100,000 | |
| 2025-04-03 | 2025-04-01 | PS Planned sale |
Chief Medical Officer Officer |
22,406
-16.1%
16.77USD 375,749 |
22,406 -16.1% | 16.77 | USD 375,749 | |
| 2025-04-03 | 2025-04-01 | PS Planned sale |
Chief Medical Officer Officer |
2,791
-2.0%
16.02USD 44,717 |
2,791 -2.0% | 16.02 | USD 44,717 | |
| 2025-04-03 | 2025-04-01 | PS Planned sale |
Chief Medical Officer Officer |
30,574
-17.7%
15.00USD 458,543 |
30,574 -17.7% | 15.00 | USD 458,543 | |
| 2025-03-17 | 2025-03-13 | B Purchase | Large shareholder |
600,000
+11.8%
13.50USD 8,100,000 |
600,000 +11.8% | 13.50 | USD 8,100,000 | |
| 2025-03-17 | 2025-03-13 | B Purchase | Non-Executive Director |
600,000
+11.8%
13.50USD 8,100,000 |
600,000 +11.8% | 13.50 | USD 8,100,000 | |
| 2025-03-17 | 2025-03-13 | B Purchase | Non-Executive Director |
1,296,296
+43.4%
13.50USD 17,499,996 |
1,296,296 +43.4% | 13.50 | USD 17,499,996 | |
| 2025-01-15 | 2025-01-13 | PS Planned sale |
Chief Executive Officer Executive Director |
18,333
-2.0%
9.06USD 166,082 |
18,333 -2.0% | 9.06 | USD 166,082 | |
| 2025-01-15 | 2025-01-13 | PS Planned sale |
CFO and Secretary Officer |
100
-0.0%
9.63USD 963 |
100 -0.0% | 9.63 | USD 963 | |
| 2025-01-15 | 2025-01-13 | PS Planned sale |
CFO and Secretary Officer |
10,657
-4.5%
9.09USD 96,901 |
10,657 -4.5% | 9.09 | USD 96,901 | |
| 2024-11-12 | 2024-11-11 | PS Planned sale |
Chief Medical Officer Officer |
5,026
-3.4%
15.00USD 75,398 |
5,026 -3.4% | 15.00 | USD 75,398 | |
| 2024-11-08 | 2024-11-06 | PS Planned sale |
Chief Medical Officer Officer |
25,482
-15.8%
15.03USD 383,066 |
25,482 -15.8% | 15.03 | USD 383,066 | |
| 2024-10-15 | 2024-10-11 | PS Planned sale |
CFO and Secretary Officer |
10,757
-4.3%
13.57USD 146,004 |
10,757 -4.3% | 13.57 | USD 146,004 | |
| 2024-10-15 | 2024-10-11 | PS Planned sale |
Chief Executive Officer Executive Director |
15,271
-1.7%
13.52USD 206,433 |
15,271 -1.7% | 13.52 | USD 206,433 | |
| 2024-07-26 | 2024-07-24 | S Sale | Non-Executive Director Large shareholder |
550,000
-6.0%
13.05USD 7,177,500 |
550,000 -6.0% | 13.05 | USD 7,177,500 | |
| 2024-07-18 | 2024-07-16 | PS Planned sale |
Chief Medical Officer Officer |
525
-0.5%
15.00USD 7,876 |
525 -0.5% | 15.00 | USD 7,876 | |
| 2024-07-12 | 2024-07-11 | PS Planned sale |
Chief Executive Officer Executive Director |
15,746
-1.7%
13.34USD 210,075 |
15,746 -1.7% | 13.34 | USD 210,075 | |
| 2024-07-12 | 2024-07-11 | PS Planned sale |
CFO and Secretary Officer |
10,757
-4.2%
13.14USD 141,394 |
10,757 -4.2% | 13.14 | USD 141,394 | |
| 2024-06-20 | 2024-06-20 | PS Planned sale |
Chief Executive Officer Executive Director |
14,940
-1.6%
11.73USD 175,237 |
14,940 -1.6% | 11.73 | USD 175,237 | |
| 2024-06-20 | 2024-06-18 | PS Planned sale |
Chief Executive Officer Executive Director |
16,607
-1.7%
11.99USD 199,073 |
16,607 -1.7% | 11.99 | USD 199,073 | |
| 2024-06-20 | 2024-06-17 | PS Planned sale |
Chief Executive Officer Executive Director |
17,766
-1.8%
12.25USD 217,712 |
17,766 -1.8% | 12.25 | USD 217,712 | |
| 2024-06-14 | 2024-06-14 | PS Planned sale |
Chief Executive Officer Executive Director |
16,229
-1.6%
12.52USD 203,163 |
16,229 -1.6% | 12.52 | USD 203,163 | |
| 2024-06-14 | 2024-06-13 | PS Planned sale |
Chief Executive Officer Executive Director |
39,961
-3.9%
12.74USD 509,027 |
39,961 -3.9% | 12.74 | USD 509,027 | |
| 2024-06-14 | 2024-06-12 | PS Planned sale |
Chief Executive Officer Executive Director |
16,607
-1.6%
12.77USD 212,013 |
16,607 -1.6% | 12.77 | USD 212,013 | |
| 2024-06-13 | 2024-06-11 | PS Planned sale |
CFO and Secretary Officer |
96,815
-27.5%
12.94USD 1,252,718 |
96,815 -27.5% | 12.94 | USD 1,252,718 | |
| 2024-05-10 | 2024-05-09 | PS Planned sale |
Chief Medical Officer Officer |
100
-0.1%
15.00USD 1,500 |
100 -0.1% | 15.00 | USD 1,500 | |
| 2024-02-14 | 2024-02-12 | B Purchase | Large shareholder |
555,555
+12.3%
13.50USD 7,499,993 |
555,555 +12.3% | 13.50 | USD 7,499,993 | |
| 2023-11-27 | 2023-11-22 | B Purchase |
Chief Executive Officer Executive Director |
4,250
+0.4%
5.97USD 25,356 |
4,250 +0.4% | 5.97 | USD 25,356 | |
| 2023-09-08 | 2023-09-06 | B Purchase |
Chief Executive Officer Executive Director |
2,250
+0.2%
12.08USD 27,180 |
2,250 +0.2% | 12.08 | USD 27,180 | |
| 2023-08-21 | 2023-08-17 | B Purchase |
Chief Executive Officer Executive Director |
2,250
+0.2%
12.10USD 27,225 |
2,250 +0.2% | 12.10 | USD 27,225 | |
| 2023-08-11 | 2023-08-11 | B Purchase |
Chief Executive Officer Executive Director |
2,000
+0.2%
12.89USD 25,780 |
2,000 +0.2% | 12.89 | USD 25,780 | |
| 2023-08-11 | 2023-08-11 | S Sale |
Chief Medical Officer Officer |
76,182
-100.0%
12.81USD 975,891 |
76,182 -100.0% | 12.81 | USD 975,891 | |
| 2023-08-11 | 2023-08-11 | S Sale |
Chief Medical Officer Officer |
80,909
-100.0%
12.81USD 1,036,444 |
80,909 -100.0% | 12.81 | USD 1,036,444 | |
| 2023-08-11 | 2023-08-10 | S Sale |
Chief Medical Officer Officer |
74,625
-100.0%
13.16USD 982,065 |
74,625 -100.0% | 13.16 | USD 982,065 | |
| 2023-02-16 | 2023-02-14 | B Purchase | Non-Executive Director Large shareholder |
250,000
+2.8%
16.00USD 4,000,000 |
250,000 +2.8% | 16.00 | USD 4,000,000 | |
| 2023-02-16 | 2023-02-14 | B Purchase |
HBM Healthcare Investments (Cayman) Ltd. Large shareholder |
312,500
+10.8%
16.00USD 5,000,000 |
312,500 +10.8% | 16.00 | USD 5,000,000 | |
| 2023-02-16 | 2023-02-14 | B Purchase | Non-Executive Director |
1,118,400
+579.9%
16.00USD 17,894,400 |
1,118,400 +579.9% | 16.00 | USD 17,894,400 | |
| 2023-02-16 | 2023-02-14 | B Purchase | Non-Executive Director |
131,600
+7.6%
16.00USD 2,105,600 |
131,600 +7.6% | 16.00 | USD 2,105,600 | |
| 2023-02-16 | 2023-02-14 | B Purchase | Non-Executive Director Large shareholder |
937,500
+26.2%
16.00USD 15,000,000 |
937,500 +26.2% | 16.00 | USD 15,000,000 | |
| 2023-02-16 | 2023-02-14 | B Purchase |
CFO, Chief Bus. Off. and Secy. Officer |
6,250
+1.8%
16.00USD 100,000 |
6,250 +1.8% | 16.00 | USD 100,000 |